Jb Pain Free Md Pllc Dba The York Pain Ctr

CLIA Laboratory Citation Details

2
Total Citations
25
Total Deficiencyies
11
Unique D-Tags
CMS Certification Number 39D2147959
Address 718 S Main St, Red Lion, PA, 17356
City Red Lion
State PA
Zip Code17356
Phone(717) 244-8504

Citation History (2 surveys)

Survey - October 31, 2023

Survey Type: Standard

Survey Event ID: 3ILH11

Deficiency Tags: D5213 D5221 D5429 D5775 D6094 D6121 D5209 D5221 D5413 D5775 D5785 D6121 D6124 D5209 D5213 D5413 D5429 D5785 D6094 D6124

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of the laboratory's competency assessment procedure and interview with the general supervisor (GS), the laboratory failed to follow their established procedure to assess the competency of 2 of 2 technical supervisor (TS) and 1 of 1 GS for their supervisory responsibilities performed from 11/17/2021 to the date of the survey. Findings include: 1. The laboratory's GEN 9 GEN: Competency procedure states, " Competency must be assessed for Technical Supervisor, General Supervisor, Technical Consultant, and Clinical Consultant as well as for all delegated duties at least annually. The section director or Laboratory Director is responsible for performing and recording competency assessment for high complexity testing." 2. On the day of survey, 10/31/2023 at 11:30 am, the laboratory failed to provide site specific competency assessment records for 2 of 2 TS (CMS 209 personnel # 2, and # 8) and 1 of 1 GS (CMS 209 personnel # 3) for their supervisory responsibilities performed from 11/17/2021 to 10/31/2023. 3. The GS confirmed the findings above on 10/31/23 at 03:00 pm. D5213 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(b)(1) The laboratory must verify the accuracy of any analyte or subspecialty without analytes listed in subpart I of this part that is not evaluated or scored by a CMS- approved proficiency testing program. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 6 -- This STANDARD is not met as evidenced by: Based on review of the laboratory's procedures, College of American Pathologists (CAP) proficiency testing (PT) records and interview with the general supervisor (GS), the laboratory failed to verify the accuracy of the PT results obtained for 4 of 4 CAP chemistry testing events reviewed for 2023. Findings include: 1. The laboratory's GEN 11 GEN: Proficiency Testing procedure states, " Ungraded PT challenges such as: Results submitted after the cut-off date, Failure to submit results, Incorrect completion of the result, PT challenges that were not graded because of lack of consensus, and All other ungraded PT results will be reviewed and evaluated against the participant summary and/or materials provided by the PT vendor." 2. On the day of survey, 10/19/2023 at 09:54 am, review of the laboratory's CAP PT records revealed that the laboratory did not verify the accuracy for the following 4 of 4 CAP chemistry testing events for 2023 that were not graded by the PT agency: - Drug Monitoring for Pain Management (DMPM-A-2023, DMPM-B-2023) -Urine Drug Adulterant/Integrity (DAI-A-2023, DAI-A-2023) 3. The CAP's actions laboratories should take when a PT result is not graded document states, "the laboratory is required to review participant summary for comparative results and document performance accordingly. Evaluation criteria is not established for educational challenges. Laboratories should determine their own evaluation criteria approved by their laboratory director for self-evaluation." 4. The GS confirmed the findings above on 10 /31/2023 at 03:00 pm D5221 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(d) All proficiency testing evaluation and verification activities must be documented. This STANDARD is not met as evidenced by: Based on a review of the College of American Pathologists (CAP), and Pennsylvania Department of Health Drugs of Abuse (PA DOH DOA) proficiency testing (PT) records and interview with the general supervisor (GS), the laboratory failed to document the evaluation and verification activities for PT testing performed in chemistry (toxicology) from 11/17/2021 to the date of the survey. Findings Include: 1. On the day of the survey, 10/31/2023 at 09:54 am, review of PT records revealed that the laboratory did not document the review and

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 20, 2019

Survey Type: Standard

Survey Event ID: PM9511

Deficiency Tags: D5209 D6094 D6094 D5407 D5407

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of laboratory procedure manuals and interview with technical supervisor (TS), the laboratory failed to establish a complete procedure to assess the competency of 1 of 1 TS competency in 2019. Findings Include: 1. On the day of survey, 11/20/2019, the laboratory failed to provide a complete written policy to assess the competency 1 of 1 TS competency in 2019. 2. The TS confirmed the finding above on 11/20/2019 around 09:00 am. D5407 PROCEDURE MANUAL CFR(s): 493.1251(d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on review of policies/ procedures and interview with the technical supervisor (TS), the laboratory failed to ensure policies/ procedures (19 out of 19) were approved, signed, and dated by the current laboratory director (LD) before use on 7/24 /2019. Findings Include: 1. On the day of survey, 11/20/2019, review of laboratory policies/ procedures (19 out of 19) revealed, the current LD (start date of 7/23/2019), did not approve, sign, and date laboratory procedures before patient testing began on 7 /24/2019. 2. The policies/ procedures were signed by the LD on the following dates: - Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- 15 out of 19 policies: 9/10/2019. - 1 out of 19 policies (Maintenance policy): 11/14 /2019. - 1 out of 19 policies (Carolina Liquid Chemistries 800 clinical Chemistry Analyzers policy): 11/18/2019. - 1 out of 19 policies (Quality Assessment policy): 11 /18/2019. - 1 out of 19 policies (Sample preparation Policy) was not signed by the LD 2. On 11/20/2019 around 10:30 am, the TS confirmed that the LD did not sign policies/ procedures before patient testing began on 7/24/2019. D6094 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality assessment programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on review of laboratory quality assurance procedure, quality assurance records and interview with technical supervisor (TS), the laboratory failed to ensure that quality assessment (QA) programs were documented and reviewed to assure the quality of laboratory from July 2019 to October 2019 (4 of 4 months). Findings Include: 1. On the day of survey, 11/20/2019, review of QA records revealed, the laboratory director (LD) did not sign monthly QA activities documented from July, August, September and October of 2019 (4 of 4 months) until 11/14/2019. 2. The TS confirmed the finding above on 11/20/2019 around 9:40 am. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access